Document is current
Any future updates will be listed below
-
Authors
Komninos, Nektarios
De Chiara, Serena
Checa, Antonio
Wiklander, Oscar
Rydberg, Per
Hedayati, Elham
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 14 May 2025
Accepted: 17 September 2025
First Online: 29 September 2025
Declarations
:
: Elham Hedayati receives research funding from Roche and Pierre Fabre, all paid to Karolinska University Hospital. Elham Hedayati and Per Rydberg are co-founders of True Dose AB and have an ownership interest (including patents) in the company. Nektarios Komninos and Serena De Chiara are employed by True Dose AB. Antonio Checa and Oscar Wiklander declare no competing interests.
: Ethics Review Committee Dnr: 20I5/12335-3I/2 with following amendment 2019-02745 and 2024-02661-0.
